News
TGTX surges 200% in 2023 on Briumvi's MS success. With Q1'25 earnings ahead, see here for TGTX stock's sales trends, new ...
We recently published a list of 10 Best Multibagger Penny Stocks to Buy According to Billionaires. In this article, we are ...
Vertex Pharmaceuticals (NASDAQ: VRTX) had a fine Tuesday on the stock exchange. The biotech's shares closed the day nearly 3% ...
12h
Investor's Business Daily on MSNStock Market Today: Dow Jones, S&P 500 Erase Losses; This Biotech Revisits Buy Zone (Live Coverage)The Nasdaq joined the Dow with a 2.7% gain. The Russell 2000 kept pace with the major indexes, also posting a 2.7% jump.
SEATTLE, WA / ACCESS Newswire / April 22, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company focused on developing novel immune-oncology ...
UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...
Eupraxia Pharmaceuticals Inc.’s EPRX share price has surged by 5.46%, which has investors questioning if this is right time ...
Regeneron, Roche Launch Major US Expansion Plans to Meet Growing Demand for Biologics and Innovation
With combined investments exceeding $53 billion, both companies are deepening their US presence through expanded biologics ...
Danaher Corporation’s DHR share price has surged by 6.12%, which has investors questioning if this is right time to sell.
The decision was made at the commission’s 952nd meeting held on Tuesday (22 April), according to a press release signed by BSEC Director and spokesperson Abul Kalam ...
When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects.
There are four emerging powerhouses in China biotech: Henlius, BeiGene, Innovent and ZaiLab. All were founded in the 2010s, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results